The effect silver nanoparticles in the healing of skin wounds

Evaluation of the effect of alginate gel containing silver nanoparticles in the healing of skin wounds - Phase 1 and 2 clinical trial

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230408057844N1

Enrollment

Registered

2023-04-12

Start date

2023-04-08

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

wound healing.

Interventions

Intervention 1: Intervention group: In this group, after washing the wound with normal saline, patients put silver gel on the site and put a protective dressing on it. Intervention 2: Control group: I

Eligibility

Sex/Gender

All

Age

18 Years to 95 Years

Inclusion criteria

Inclusion criteria: Conditions for entering the study: age between 18 and 95 years old, having grade 2 wounds, no history of antibiotic use, conditions for leaving the study: patients who do not want to continue the clinical trial for any reason. Patients with underlying diseases such as uncontrolled diabetes, autoimmune diseases, or patients undergoing chemotherapy drugs, etc. Wound infection. In these cases, the patient will be removed from the research units and the treatment method will be changed according to the doctor's opinion.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Degree of wound, presence or absence of infection. Timepoint: Days zero, 3, 7 and 10. Method of measurement: Examining the size of the wound and using a ruler and ImageJ software, examining microbial cultures.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohamad Javad Mirzaei-Parsa

Kerman University of Medical Sciences

mj.mirzaei@kmu.ac.ir+98 34 3121 5682

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026